Net Cash Provided by (Used in) Operating Activities |
-1.2K |
USD |
+94.5% |
Q1 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
1.05K |
USD |
-95.2% |
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
290M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
242M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-150 |
USD |
-170% |
Q1 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
61 |
USD |
-95.3% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
723K |
USD |
-9.05% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Additional Paid in Capital |
3.18M |
USD |
0% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
801K |
USD |
+0.91% |
Q3 2023 |
Q3 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |